Literature DB >> 26962393

Muir-Torre Syndrome: A Case Associated with an Infrequent Gene Mutation.

Alexandra Grob1, Christina Feser1, Steven Grekin1.   

Abstract

Muir-Torre syndrome is a rare, autosomal dominant genodermatosis characterized by the presence of at least one sebaceous gland neoplasm, associated with an underlying visceral malignancy. Muir-Torre syndrome is believed to be a subtype of Lynch Syndrome. Affected individuals are found to have germline mutations predominantly in DNA mismatch repair gene MSH2, and much less frequently, MLH1. The authors report the case of a 55-year-old woman presenting with multiple cutaneous neoplasms including sebaceoma, basal cell carcinoma, and squamous cell carcinoma; personal history of colorectal and endometrial cancer; and family history of colorectal cancer; found to have a deletion at mismatch repair gene MLH1. It is important to recognize the role of these less common gene deletions in producing the Muir-Torre syndrome phenotype, and consider the correlation of cutaneous manifestations with internal disease. The authors discuss the clinical presentation of Muir-Torre syndrome, methods of diagnosis, and the importance of regular medical surveillance to detect and prevent disease progression in Muir-Torre syndrome patients and their family members.

Entities:  

Year:  2016        PMID: 26962393      PMCID: PMC4756873     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  15 in total

1.  A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome.

Authors:  E Mangold; C Pagenstecher; M Leister; M Mathiak; A Rütten; W Friedl; P Propping; T Ruzicka; R Kruse
Journal:  J Med Genet       Date:  2004-07       Impact factor: 6.318

2.  Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomas.

Authors:  Giovanni Ponti; Lorena Losi; Monica Pedroni; Emanuela Lucci-Cordisco; Carmela Di Gregorio; Giovanni Pellacani; Stefania Seidenari
Journal:  J Invest Dermatol       Date:  2006-07-06       Impact factor: 8.551

3.  Muir-Torre syndrome: Diagnostic and screening guidelines.

Authors:  Brad Jones; Carol Oh; Elisabeth Mangold; Conleth A Egan
Journal:  Australas J Dermatol       Date:  2006-11       Impact factor: 2.875

Review 4.  The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications.

Authors:  Daniel C Chung; Anil K Rustgi
Journal:  Ann Intern Med       Date:  2003-04-01       Impact factor: 25.391

5.  Frequency of microsatellite instability in unselected sebaceous gland neoplasias and hyperplasias.

Authors:  Roland Kruse; Arno Rütten; Nadine Schweiger; Eva Jakob; Micaela Mathiak; Peter Propping; Elisabeth Mangold; Michele Bisceglia; Thomas Ruzicka
Journal:  J Invest Dermatol       Date:  2003-05       Impact factor: 8.551

Review 6.  Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm.

Authors:  Ossama Abbas; Meera Mahalingam
Journal:  J Cutan Pathol       Date:  2009-06       Impact factor: 1.587

7.  Sebaceoma. A distinctive benign neoplasm of adnexal epithelium differentiating toward sebaceous cells.

Authors:  J L Troy; A B Ackerman
Journal:  Am J Dermatopathol       Date:  1984-02       Impact factor: 1.533

8.  Muir-Torre syndrome: a rare but important disorder.

Authors:  Holly H Hare; Neetu Mahendraker; Sandhya Sarwate; Krishnarao Tangella
Journal:  Cutis       Date:  2008-10

9.  Sebaceous neoplasia and Torre-Muir syndrome.

Authors:  A J F Lazar; S Lyle; E Calonje
Journal:  Curr Diagn Pathol       Date:  2007-08

Review 10.  Sebaceous lesions and their associated syndromes: part II.

Authors:  Daniel B Eisen; Daniel J Michael
Journal:  J Am Acad Dermatol       Date:  2009-10       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.